Jeff Zients, the White House COVID-19 response coordinator, spoke with ABC News' Martha Raddatz on Sunday's edition of This Week, during which he addressed the fact that the White House fell short of reaching its goal of vaccinating 70 percent of U.S. adults by July 4.
"Younger people, particularly those in their 20s, have felt less vulnerable to the disease and therefore less eager to get shots," he said, though he added that the age group was made eligible later so "we continue to see hundreds of thousands of young people vaccinated each week."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Why does Elon Musk take his son everywhere?Talking Point With his four-year-old 'emotional support human' by his side, what message is the world's richest man sending?
-
The Week Unwrapped: Why are sinkholes becoming more common?Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
-
How Poland became Europe's military powerThe Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
HMPV is spreading in China but there's no need to worryThe Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDAIn the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
